Considering that PCSK9 levels are inversely correlated with markers of intratumoral T-cell infiltration and survival in PC patients, it will be interesting to study whether the combination of PCSK9-neutralizing antibodies with immune checkpoint blockade may be beneficial also in PC. The gene discussed is PCSK9; the disease is pachyonychia congenita.